The prognostic value of ULBP2 was also reported in B-cell chronic lymphocytic leukemia (CLL), and the expression in 98 patients with CLL and 48 healthy participants as the control group was analyzed by means of ELISA. This evidence concerns the gene ULBP2 and B-cell chronic lymphocytic leukemia.